Cancer Immunotherapy: accelerating preclinical drug candidate selection using the full advanced human immune system mouse models.

The Do’s and Don’ts by the TransCure bioServices Experts.

April 30th, 2020

Sebastien Tabruyn, PhD Chief Scientific Officer (CSOHosted online by
Sebastien Tabruyn, PhD, CSO
for a 45 minutes presentation.

Download the presentation and watch the full replay:

  • Ask for your full access via the form 

You will learn:

  • Which are the main characteristics of a predictive IO full human immune system mouse model ?
  • How to select the best cancer cell lines or PDX ?
  • Why is the transient human cytokines boosting developed by TransCure bioServices superior to all constitutive mouse models for increasing NK-cell dependent mechanisms and myeloid cell lineage differentiation?
  • Several case study will presented in details: immune check-point inhibitions; bi-specific mAb; ADCC mediated effects; Car-T cell strategy; Oncolytic viruses/bacteria; microbiota influence; vaccine strategies.

Who is Sebastien Tabruyn?

Sebastien Tabruyn, PhD Chief Scientific Officer (CSO). He holds a PhD in Molecular Biology from the University of Liege (Belgium). After 15 years of experience as Project leader in renowned international academic research institutes including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia) and the University of Maastricht (Netherlands), he joined TransCure bioServices in 2013 as Head of Molecular Biology and Oncology. Sebastien Tabruyn published 35 peer-reviewed publications in the field of Oncology, Angiogenesis, Inflammation and Immunity.

    Instant webinar access

    Our latest news

    Science VS Sars-Cov-2: science could win

    Science could win We all know that 2021 will go into mostly everyone´s history book as the vaccine year against the COVID-19 pandemic.  It made us realize why science is key to understand viruses, bacteria and the interactions between humans and their environment. We...

    New Disease Model: human hepatocytes (hu-liver) Mouse Models

    TransCure bioServices launches its human hepatocytes (hu-liver) mouse models! Innovative preclinical model thanks to TransCure bioServices ! Our initial human hepatocyte liver disease model (hu-PIRF) has now been fully validated in house thanks to our collaboration...

    Brand New Rodent Animal Facility at TransCure bioServices

    State-of-the-Art and Expanded Animal Facilities at TransCure bioServices We have totally refurbished and remodeled our extended animal facility (now more than 500 m2 – upgraded 300 m2 last year) with automatic sliding doors, several dedicated rooms for...

    Webinar 2021 Sessions in Immuno-Oncology, IBD and Infectious Diseases

    Webinar 2020 Series: Immuno-Oncology, IBD, and Infectious Diseases are available here. In mid-2020, our CSO Dr. Sebastien Tabruyn, PhD hosted our first webinar-series focusing on our core expertise: immuno-oncology, inflammation and infectious disease using full human...

    Our profession:
    in vivo pharmacology services

    Please feel free to contact us


    Share this!